The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2017

Filed:

Jan. 13, 2015
Applicant:

The United States of America, As Represented BY the Secretary, Dept. of Health and Human Services, Washington, DC (US);

Inventors:

Zhaochun Chen, North Potomac, MD (US);

Robert H. Purcell, Gaithersburg, MD (US);

Suzanne U. Emerson, Gaithersburg, MD (US);

Stephen H. Leppla, Bethesda, MD (US);

Mahtab Moayeri, Bethesda, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/573 (2006.01); C07K 16/12 (2006.01); C07K 16/40 (2006.01); A61K 51/10 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1278 (2013.01); A61K 51/1009 (2013.01); C07K 16/40 (2013.01); G01N 33/56911 (2013.01); G01N 33/573 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/32 (2013.01); G01N 2333/954 (2013.01); G01N 2469/10 (2013.01);
Abstract

The present invention relates to monoclonal antibodies that bind or neutralize anthrax lethal factor (LF), edema factor (EF), and/or protective antigen (PA). The invention provides such antibodies, fragments of such antibodies retaining anthrax toxin-binding ability, fully human or humanized antibodies retaining anthrax toxin-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention.


Find Patent Forward Citations

Loading…